Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

October 31, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Alzheimer's Disease

Interventions

DRUG

Rilapladib 25 mg

White, round, biconvex, film coated tablet of 25 mg. Taken orally along with food.

DRUG

Rilapladib 250 mg

White, round, biconvex, film coated tablet of 250 mg. Taken orally along with food.

DRUG

Itraconazole

100 mg capsule with a blue opaque cap and pink transparent body. Taken orally along with food.